Effect of Hepatocyte Targeting Nanopreparation Syringopicroside on Duck Hepatitis B Virus and Evaluation of Its Safety.

Zhang, X W; Li, M C; Dou, J J

Zhang, X W; Li, M C; Dou, J J.

Zhang XW; Research Institute of Traditional Chinese Medicine, Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang, China.
Li MC; Research Institute of Traditional Chinese Medicine, Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang, China.
Dou JJ; Research Institute of Traditional Chinese Medicine, Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang, China. doujinjin1980@126.com.

Bull Exp Biol Med ; 172(5): 573-578, 2022 Mar.

Article en En | MEDLINE | ID: mdl-35352245

Asunto(s)

Virus de la Hepatitis B del Pato; Hepatitis B; Animales; ADN Viral/genética; Glicósidos; Células Hep G2; Hepatitis B/tratamiento farmacológico; Virus de la Hepatitis B del Pato/genética; Antígenos e de la Hepatitis B/farmacología; Antígenos e de la Hepatitis B/uso terapéutico; Virus de la Hepatitis B/genética; Humanos; Ratones; Ratones Endogámicos ICR; Replicación Viral

Palabras clave

fluorescence quantitative PCR; hepatitis B virus; hepatoprotective effect; syringopicroside PLGA nanoparticles

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus de la Hepatitis B del Pato / Hepatitis B Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google